These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 4307911)

  • 41. The value of combined blood phosphatase and sedimentation rate determinations in the diagnosis of metastasis in prostatic carcinoma.
    BOYLAN RN; TILLISCH JH
    J Urol; 1948 May; 59(5):931-4. PubMed ID: 18913856
    [No Abstract]   [Full Text] [Related]  

  • 42. [Medical aspects of cancer of the prostate].
    Bercovici S; Georgescu M; Ioachim A
    Med Interna (Bucur); 1971 Nov; 23(11):1377-87. PubMed ID: 5134699
    [No Abstract]   [Full Text] [Related]  

  • 43. Prostatic serum acid phosphatase as an aid in the diagnosis of prostatic carcinoma; preliminary report.
    BAURYS W; WENTZELL RA
    Guthrie Clin Bull; 1956 Oct; 26(2):72-6. PubMed ID: 13397847
    [No Abstract]   [Full Text] [Related]  

  • 44. [Diagnosis of skeletal metastases in prostatic cancer using gamma camera (author's transl)].
    Langhammer H; Sintermann R; Kempken K; Hör G; Pabst HW; Fendl M
    Med Klin; 1977 May; 72(21):942-51. PubMed ID: 875870
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Value of determination of phosphatases in determination of prostatic cancer].
    WOJEWSKI A
    Urol Pol; 1956; 9():35-42. PubMed ID: 13401602
    [No Abstract]   [Full Text] [Related]  

  • 46. Fluoride therapy for pain in malignant bone disease.
    Scott WP
    Radiology; 1968 Mar; 90(3):588-90. PubMed ID: 4966742
    [No Abstract]   [Full Text] [Related]  

  • 47. Some factors other than neoplasms altering the prostatic fraction of acid phosphatase in the serum.
    BONNER CD; HOMBURGER F; FISHMAN WH
    Surg Gynecol Obstet; 1954 Aug; 99(2):179-83. PubMed ID: 13187197
    [No Abstract]   [Full Text] [Related]  

  • 48. Prostate cancer.
    Guthrie TH; Watson P
    Am Fam Physician; 1987 Oct; 36(4):217-24. PubMed ID: 3314438
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Early diagnosis of metastases in prostatic carcinoma].
    Rutishauser G
    Dtsch Med Wochenschr; 1972 Sep; 97(35):1304-5. PubMed ID: 5050244
    [No Abstract]   [Full Text] [Related]  

  • 50. [Treatment of advanced prostatic cancer].
    Fosså SD; Miller A
    Tidsskr Nor Laegeforen; 1975 May; 95(13):811-4. PubMed ID: 1135805
    [No Abstract]   [Full Text] [Related]  

  • 51. [On the diagnosis and therapy of prostatic cancer].
    Oertli P
    Ther Umsch; 1967 Jul; 24(7):278-82. PubMed ID: 5612683
    [No Abstract]   [Full Text] [Related]  

  • 52. [Behavior of serum phosphates in prostatic neoplasms after hormonal stimulation. (Experimental study)].
    Ronzoni G; Lojacono L; Alcini E; Landi E; Tamborini G
    Chir Patol Sper; 1967; 15(2):203-15. PubMed ID: 4302590
    [No Abstract]   [Full Text] [Related]  

  • 53. [Rate of survival in prostatic cancer with bone metastasis].
    Kuntz D; Ryckewaert A
    Rev Fr Etud Clin Biol; 1969; 14(6):609-13. PubMed ID: 5824263
    [No Abstract]   [Full Text] [Related]  

  • 54. Hypercalcemia secondary to bone metastases from carcinoma of the breast. I. Relationship between serum calcium and alkaline phosphatase values.
    GRIBOFF SI; HERRMANN JB; SMELIN A; MOSS J
    J Clin Endocrinol Metab; 1954 Apr; 14(4):378-88. PubMed ID: 13152165
    [No Abstract]   [Full Text] [Related]  

  • 55. [The metastatic prostate cancer. Effectiveness of a combination of female hormones and specific immune-stimulating therapy].
    Gutschank S; Rothauge CF; Kraushaar J; Gutschank W; Sedlacek KH
    MMW Munch Med Wochenschr; 1981 Jan; 123(4):133-4. PubMed ID: 6261127
    [No Abstract]   [Full Text] [Related]  

  • 56. [Solitary dermal metastasis of a prostatic carcinoma].
    Gallizia F; Gallizia G
    J Urol Nephrol (Paris); 1968 Jun; 74(6):487-90. PubMed ID: 5678504
    [No Abstract]   [Full Text] [Related]  

  • 57. [Use of calcitonin in the treatment of bone metastases of prostatic carcinoma].
    Di Silverio F; Giacobini S; Liberti M; Fragomeri R; Petrone U
    Clin Ter; 1977 Oct; 83(1):3-15. PubMed ID: 589946
    [No Abstract]   [Full Text] [Related]  

  • 58. [ROENTGENOLOGICAL EVALUATION OF OSSEOUS METASTASES OF PROSTATIC NEOPLASMS].
    EVDOKIMOVA VM; PERELMAN VM
    Vopr Onkol; 1964; 10():42-7. PubMed ID: 14229416
    [No Abstract]   [Full Text] [Related]  

  • 59. [A CASE OF GENERALIZED OSTEOPLASTIC BONE METASTASES IN PROSTATIC CANCER].
    LUKOMSKI E
    Pol Tyg Lek; 1964 Nov; 19():1739-40. PubMed ID: 14321006
    [No Abstract]   [Full Text] [Related]  

  • 60. Correlation of pre-treatment serum 17-hydroxycorticosteroid values with survival in patients with prostatic cancer.
    Blackard CE; Byar DP; Seal US; Doe RP
    J Urol; 1975 Apr; 113(4):517-20. PubMed ID: 163929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.